Full Access
PLATELET-RICH PLASMA 5-HYDROXYTRYPTAMINE, URINARY 5-HYDROXYINDOLEACETIC ACID AND TRYPTOPHAN INGESTION IN MONGOLS
EILA M. AIRAKSINEN,
Corresponding Author
EILA M. AIRAKSINEN
Departments of Pharmacology and Neurology, University of Helsinki and Rinnekoti Institution for the Mentally Retarded, Majalampi, Finland
Address of the author: Department of Pharmacology, University of Helsinki, Siltavuoren-penger 10, Helsinki 17, Finland.Search for more papers by this authorEILA M. AIRAKSINEN,
Corresponding Author
EILA M. AIRAKSINEN
Departments of Pharmacology and Neurology, University of Helsinki and Rinnekoti Institution for the Mentally Retarded, Majalampi, Finland
Address of the author: Department of Pharmacology, University of Helsinki, Siltavuoren-penger 10, Helsinki 17, Finland.Search for more papers by this author
REFERENCES
- Aohajanian, G. K. and Asher, I. M. (1971) Histochemical fluorescence of raphe neurons: selective enhancement by tryptophan. Science, 172, 1159.
- Airaksinen, M. M., Giacalone, E. and Valzelli, L. (1968) Hydroxylation of tryptophan in the brain in vivo. J. Neurochem., 15, 55.
- Ashcroft, G. W., Crawford, T. B. B., Binns, J. K. and Macdougall, E. J. (1964) Estimation of 5-hydroxytryptamine in human blood. Clinica chim. Acta, 9, 364.
- Ashcroft, G. W. and Sharman, D. F. (1962) Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus. Brit. J. Pharmacol., 19, 153.
- Bazelon, M., Paine, R. S., Cowie, V. A., Hunt, P., Houck, J. C. and Mahanand, D. (1967) Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxy-tryptophan. Lancet, 1, 1130.
- Berman, J., Hulten, M. and Lindsten, J. (1967) Blood-serotonin in Down's syndrome. Ibid., 1, 730.
- Berman, J. L., Justice, P. and Hsia, D. Y. (1965) The metabolism of 5-hydroxytryptamine (serotonin) in the newborn. J. Pediat., 67, 603.
- Bertler, A., Falck, B. and Rosengren, E. (1963) The direct demonstration of a barrier mechanism in the brain capillaries. Acta pharmacol. et toxicol., 20, 317.
- Bogdanski, D. F., Pletscher, A., Brodie, B. B. and Udenfriend, S. (1956) Identification and assay of serotonin in brain. J. Pharmacol. exp. Ther., 117, 82.
- Boullin, D. J. and O'Brien, R. A. (1971) Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome. J. Physiol., 212, 287.
- Careddu, P., Tenconi, L. T. and Sacchetti, G. (1963) Transmethylation in mongols, Lancet, 1, 828.
- Carroll, B. J. and Dodge, J. (1971) L-tryptophan as an antidepressant. Ibid., 1, 915.
- Carroll, B. J., Mowbray, R. M. and Davies, B. (1970) Sequential comparison of l-trypto-phan with E.C.T. in severe depression. Ibid., 1, 967.
- Clark, L. C. and Thompson, H. L. (1949) Determination of creatine and creatinine in urine. An. Chem., 21, 1218.
- Contractor, S. F. (1964) The estimation of 5-hydroxytryptamine in human blood. Biochem. Pharmacol., 13, 1357.
- Coppen, A., Shaw, D. M. and Farrell, J. P. (1963) Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet, 1, 79.
- Coppen, A., Shaw, D. M., Herzberg, B. and Maggs, R. (1967) Tryptophan in the treatment of depression. Ibid., 2, 1178.
- Corrodi, H., Fuxe, K. and Hökeelt (1967) Replenishment by 5-hydroxytryptophan of the amine stores in the central 5-hydroxytryptamine neurons after depletion induced by reser-pine or by an inhibitor of monoamine synthesis. J. Pharm. Pharmac., 19, 433.
- Dubowitz, V. and Rogers, K. J. (1969) 5-Hydroxyindoles in the cerebrospinal fluid of infants with Down's syndrome and muscle hypotonia. Develop. Med. Child Neural., 2, 730.
- Ebadi, M. S. and Kugel, R. B. (1970) Alteration in metabolism of acetylsalicylic acid in children with Down's syndrome: Decreased plasma binding and formation of salicyluric acid. Pediat. Res., 4, 187.
- Eccleston, D., Ashcroft, G. W. and Crawford, T. B. B. (1970) Effect of tryptophan administration on 5-HIAA in cerebrospinal fluid in man. J. neural, neurosurg. psychiat., 33, 269.
- Feissly, R. and Mandel, P. (1954) Considerations sur le diagnostic hématologique des etats trombophiliques. Schweiz. med. Wschr., 84, 807.
- Gershoff, S. N., Hegsted, D. M. and Trulson, M. F. (1958) Metabolic studies of mongol-oids. Amer. J. Clin. Nutr., 6, 526.
- Hardisty, R. M. and Stacey, R. S. (1955) 5-Hydroxytryptamine in normal human platelets. J. Physiol. (Lond.), 130, 711.
- Horita, A. and Carino, M. A. (1970) Modification of the toxic actions of 1-tryptophan by pargyline and p-chlorophenylalanine. Biochem. Pharmacol., 19, 1521.
- Iivanainen, M., Hongell, K. and Gripenbero, U. (1970) The occurrence of translocations and their forms in Finnish mongoloids. Scand. J. clin. Lab. Invest., 113, Suppl. 25, 60.
- Jéquier, E., Lovenberg, W. and Sjoerdsma, A. (1967) Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Molec. Pharmacol., 3, 274.
- Jérôme, H. (1962) Anomalies du metabolisme du tryptophane dans la maladie mongolienne. Bull. Soc. méd. Hôp., Paris, 113, 168.
- Jérôme, H. and Kamoun, P. (1967) Diminution du taux de la serotonine associée a un défaut de captation dans les plaquettes sanguines des sujets trisomiques 21. Compt. Rend. Acad. Sci. (Paris), 264, 2072.
- Jérôme, H. and Kamoun, P. (1970) Platelet binding of serotonin. Ann. N.Y. Acad. Sci., 171, 543.
- Jérôme, H., Lejeune, J. and Turpin, R. (1960) Étude de ľexcrétion urinaire de certains métabolites du tryptophane chez les enfants mongoliens. C. R. Acad. Sci., Paris, 251, 474.
- Knox, W. E. and Mehler, A. H. (1951) The adaptive increase of the tryptophan peroxidase-oxidase system of liver. Science, 113, 257.
- McCoy, E. E. and Chung, S. I. (1964) The excretion of tryptophan metabolites following deoxypyridoxine administration in mongoloid and non-mongoloid patients. J. Pediat., 64, 227.
- McCoy, E. E., Colombini, C. and Ebadi, M. (1969) The metabolism of vitamin B6 in Down's syndrome. Ann. N.Y. Acad. Sci., 166, 116.
- McCoy, E. E., Rostafinsky, M. J. and Fishburn, C. (1968) The concentration of serotonin by platelets in Down's syndrome. J. ment. Defic. Res., 12, 18.
- Mustala, O. (1965) Specificity of the nitrosonaphtol reaction in the determination of urinary 5-hydroxyindoleacetic acid. Ann. Med. exp. Biol. Fenn., 43, Suppl. 8.
- O'Brien, D. and Groshek, A. (1962) The abnormality of tryptophan metabolism in children with mongolism. Arch. Dis. Childh., 37, 17.
- Paasonen, M. K. and Kivalo, E. (1962) The inactivation of 5-hydroxytryptamine by blood platelets in mental deficiency with elevated serum 5-hydroxytryptamine. Psychopharmacol., 3, 188.
- Pare, C. M. B., Sandler, M. and Stacey, R. S. (1960) 5-Hydroxyindoles in mental deficiency. J. Neural. Neurosurg. Psychiat., 23, 341.
- Partington, M. W., Macdonald, M. R A. and Tu, J. B. (1971) 5-Hydroxytryptophan (5HTP) in Down's syndrome. Develop. Med. Child Neural., 13, 362.
- Persson, T. and Roos, B. E. (1967) 5-Hydroxytryptophan for depression. Lancet, 2, 987.
- Rapaport, M. I., Beisel, W. R. and Dinterman, R. E. (1968) Circadian periodicity of tryptophan metabolism. J. Clin. Invest., 47, 934.
- Rose, D. P. (1969) Oral contraceptive and depression. Lancet, 2, 321.
- Rosner, F., Ong, B. H., Paine, R. S. and Mahanand, D. (1965) Blood-serotonin activity in trisomic and translocation Down's syndrome. Ibid., 1, 1191.
- Sandler, M. (1968) Determination of hydroxyindoles in biological materials. Ann. Med. exp. Biol. Fenn., 46, 479.
- Smith, B. and Prockop, D. J. (1962) Central-nervous-system effects of ingestion of 1-trypto-phan by normal subjects. New Engl. J. Med., 26, 1338.
- Tissot, R., Guggisberg, M., Constantnindis, J. and Bettsohart, W. (1966) Excretion urinaire de ľacide 5-hydroxyindoIacetique, de ľacide vanillomandelique et de l'acide xanthurenique chez 18 mongoliens. Path. Biol., 14, 312.
- Tu., J. and Zellweger, H. (1965) Blood-serotonin deficiency in Down's syndrome. Lancet, 2, 715.
- Udenfriend, S., Titus, E. and Wessbaoh, H. (1955) The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay. J. biol. Chem., 216, 499.
- Udenfriend, S., Weissbach, H. and Brodie, B. B. (1958) Assay of serotonin and related metabolites, enzymes and drugs. Methods of Biochemical Analysis, 6, 95.
- Waalkes, T. P. (1959) The determination of serotonin (5-hydroxytryptamine) in human blood. J. Lab. Clin. Med., 53, 824.
- Vassella, F., Colombo, J. P., Gloor, R. D. and Rossi, E. (1968) Untersuchungen über den L-tryptophanstoffwechsel bei Kindern mit Down-Syndrom. Helv. Paed. Acta, 23, 419.
-
Weber, L. J. (1966) Influence of monoamine oxidase inhibitors on 5-hydroxytryptamine synthesis in the brain (31395).
Proc. Soc. exp. Biol. (N.Y.), 123, 34.
10.3181/00379727-123-31395 Google Scholar
- Weissbach, H., Andrews, E. and Seligson, H. T. (1963) The estimation of serotonin in biological material. Standard methods of clinical chemistry, 4, 197.
